Original Research
Published on 16 May 2025
Metabolic reprogramming signature predicts prognosis and immune landscape in small cell lung cancer: MOCS2 validation and implications for personalized therapy
in Metabolomics
- 1,423 views
Original Research
Published on 16 May 2025
in Metabolomics
Original Research
Published on 09 May 2025
in Metabolomics
Original Research
Published on 08 May 2025
in Metabolomics
Original Research
Published on 30 Apr 2025
in Metabolomics
Original Research
Published on 28 Apr 2025
in Metabolomics
Original Research
Published on 25 Apr 2025
in Metabolomics
Original Research
Published on 16 Apr 2025
in Metabolomics
Original Research
Published on 09 Apr 2025
in Metabolomics
Original Research
Published on 09 Apr 2025
in Metabolomics
Editorial
Published on 08 Apr 2025
in Metabolomics
Original Research
Published on 07 Apr 2025
in Metabolomics
Editorial
Published on 28 Mar 2025
in Metabolomics
Brief Research Report
Published on 26 Mar 2025
in Metabolomics
Original Research
Published on 25 Mar 2025
in Metabolomics
Original Research
Published on 20 Mar 2025
in Metabolomics
Original Research
Published on 17 Mar 2025
in Metabolomics